Opportunities for telepharmacy

Abstract

Telepharmacy, the provision of pharmaceutical care through telecommunications to patients in locations where they may not have direct contact with a pharmacist, is gaining momentum globally. This dissertation investigates the opportunities, challenges, and policy implications of telepharmacy implementation across five countries India, China, Spain, Germany, and Sweden representing diverse healthcare systems, income levels, and digital readiness. Through a literature review of over 36 peer reviewed studies, government policy documents, and global health reports, this research examines key themes including access to pharmaceutical care, medication safety, cost-effectiveness, digital infrastructure, and regulatory frameworks. The findings indicate that telepharmacy enhances medication access and continuity of care, particularly in underserved rural regions, and contributes significantly to improving medication adherence and safety. Spain, Germany, and Sweden demonstrate mature telepharmacy systems integrated within national e-health strategies, while India and China exhibit innovative yet fragmented adoption patterns, with rural infrastructure and policy gaps acting as major barriers. A thematic analysis reveals that regulatory clarity, digital infrastructure, pharmacist training, and patient digital literacy are central to successful implementation. The study also finds that telepharmacy aligns well with global health targets such as Universal Health Coverage and the WHO's digital health strategies. It underscores the need for formal policy development, public-private collaboration, and national training frameworks to ensure sustainable integration. By presenting a comparative analysis supported by country specific data and international best practices, this dissertation provides strategic insights for policymakers, healthcare professionals, and academic stakeholders. It advocates for mainstreaming telepharmacy as a core health service delivery model to bridge access gaps, improve pharmaceutical care, and build resilient healthcare systems in a digitally transforming world.